For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Prior to the opening of the market on 18 December 2019, Pharmaxis Ltd (PXS) will announce the advice the company has received from Boehringer Ingelheim (BI) concerning BI’s future development plans for the drug it acquired from Pharmaxis in 2015.
That announcement will have the effect of lifting the current trading halt over the company’s shares.
The company will hold an investor teleconference at 9.15am (AEDT) after release of the announcement.
Conference call access information is detailed in the attached.Read full media release - pdf